Skip to main content

Table 2 Demographic and clinical characteristics of lornoxicam treated and placebo patients

From: Effects of lornoxicam on the physiology of severe sepsis

Characteristic Lornoxicam group (n = 20) Placebo group (n = 20)
Age (years [range]) 49 (19–87) 51 (20–89)
Sex (male/female) 13/7 9/11
Source of infection   
Respiratory 15 17
Gastrointestinal 2 1
Blood 2 1
Urinary tract 1 1
APACHE II scorea 17.10 ± 3.58 18 ± 3.72
SOFA scorea 5.90 ± 1.72 6.20 ± 2.2
Duration of ventilationa 6.1 ± 2.4 5.8 ± 3.1
Length of staya 10.2 ± 7.1 9.2 ± 8.4
Mortality rate (%) 35 40
  1. There were no significant differences between the groups. aValues are expressed as mean ± standard deviation. APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sepsis-related (or Sequential) Organ Failure Assessment.